Alphatec Holdings [ATEC] vs Boston Scientific [BSX] Detailed Stock Comparison

Alphatec Holdings

NASDAQ
Loading...

Boston Scientific

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Alphatec Holdings wins in 6 metrics, Boston Scientific wins in 12 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlphatec HoldingsBoston ScientificBetter
P/E Ratio (TTM)-12.3557.93Alphatec Holdings
Price-to-Book Ratio86.176.43Boston Scientific
Debt-to-Equity Ratio1,238.2953.09Boston Scientific
PEG Ratio1.790.40Boston Scientific
EV/EBITDA-167.8233.14Alphatec Holdings
Profit Margin (TTM)-24.33%13.55%Boston Scientific
Operating Margin (TTM)-6.19%18.63%Boston Scientific
EBITDA Margin (TTM)N/A18.63%N/A
Return on Equity-376.89%11.55%Boston Scientific
Return on Assets (TTM)-7.61%5.39%Boston Scientific
Free Cash Flow (TTM)$-137.79M$2.37BBoston Scientific
1-Year Return164.08%11.02%Alphatec Holdings
Price-to-Sales Ratio (TTM)3.037.80Alphatec Holdings
Enterprise Value$2.52B$155.93BBoston Scientific
EV/Revenue Ratio3.698.43Alphatec Holdings
Gross Profit Margin (TTM)69.58%67.65%Alphatec Holdings
Revenue per Share (TTM)$5$13Boston Scientific
Earnings per Share (Diluted)$-1.13$1.68Boston Scientific
Beta (Stock Volatility)1.060.61Boston Scientific
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Alphatec Holdings vs Boston Scientific Stock Performance Analysis

Loading Price Chart...

Alphatec Holdings
Boston Scientific
Alphatec Holdings Stock Overview | Boston Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alphatec Holdings-2.58%-7.80%-16.77%24.43%35.86%50.11%
Boston Scientific-0.64%-0.35%-10.58%-6.87%5.64%8.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alphatec Holdings164.08%50.11%34.52%206.31%-54.67%-85.69%
Boston Scientific11.02%141.87%151.56%466.49%1,472.36%305.28%

News Based Sentiment: Alphatec Holdings vs Boston Scientific

Alphatec Holdings

News based Sentiment: MIXED

October was a month of conflicting signals for Alphatec, with stock declines and insider selling offset by institutional investment and positive analyst ratings. The upcoming Q3 earnings report on October 29th will be a key catalyst for the stock, making this a moderately important month for investors.

View Alphatec Holdings News Sentiment Analysis

Boston Scientific

News based Sentiment: POSITIVE

October brought a wave of positive signals for Boston Scientific, including increased institutional investment, raised price targets from multiple firms, and a promising long-range plan. While insider selling remains a point to watch, the overall narrative is one of strong growth potential and investor confidence.

View Boston Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Alphatec Holdings vs Boston Scientific

MetricATECBSX
Market Information
Market Cap i$2.22B$144.20B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,642,69712,773,240
90 Day Avg. Volume i1,921,71910,174,867
Last Close$13.60$96.70
52 Week Range$4.88 - $16.70$80.64 - $109.50
% from 52W High-18.56%-11.69%
All-Time High$105.60 (Jun 12, 2006)$109.50 (Sep 09, 2025)
% from All-Time High-87.12%-11.69%
Growth Metrics
Quarterly Revenue Growth0.28%0.23%
Quarterly Earnings Growth0.27%1.46%
Financial Health
Profit Margin (TTM) i-0.24%0.14%
Operating Margin (TTM) i-0.06%0.19%
Return on Equity (TTM) i-3.77%0.12%
Debt to Equity (MRQ) i1,238.2953.09
Cash & Liquidity
Book Value per Share (MRQ)$0.16$15.14
Cash per Share (MRQ)$1.06$0.36
Operating Cash Flow (TTM) i$15.69M$4.28B
Levered Free Cash Flow (TTM) i$21.17M$2.94B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Alphatec Holdings vs Boston Scientific

MetricATECBSX
Price Ratios
P/E Ratio (TTM) i-12.3557.93
Forward P/E i-21.4834.88
PEG Ratio i1.790.40
Price to Sales (TTM) i3.037.80
Price to Book (MRQ) i86.176.43
Market Capitalization
Market Capitalization i$2.22B$144.20B
Enterprise Value i$2.52B$155.93B
Enterprise Value Metrics
Enterprise to Revenue i3.698.43
Enterprise to EBITDA i-167.8233.14
Risk & Other Metrics
Beta i1.060.61
Book Value per Share (MRQ) i$0.16$15.14

Financial Statements Comparison: Alphatec Holdings vs Boston Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ATECBSX
Revenue/Sales i$169.18M$4.66B
Cost of Goods Sold i$53.18M$1.45B
Gross Profit i$116.00M$3.21B
Research & Development i$16.58M$443.00M
Operating Income (EBIT) i$-31.71M$937.00M
EBITDA i$-10.19M$1.23B
Pre-Tax Income i$-51.97M$805.00M
Income Tax i$-64,000$133.00M
Net Income (Profit) i$-51.91M$672.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ATECBSX
Cash & Equivalents i$153.24M$725.00M
Total Current Assets i$434.89M$7.34B
Total Current Liabilities i$157.87M$5.06B
Long-Term Debt i$572.40M$10.93B
Total Shareholders Equity i$-85.94M$22.45B
Retained Earnings i$-1.33B$3.35B
Property, Plant & Equipment i$320.90M$448.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ATECBSX
Operating Cash Flow i$-23.48M$513.00M
Capital Expenditures i$-9.93M$-187.00M
Free Cash Flow i$-16.65M$277.00M
Debt Repayment i$-321.03M$-1.31B
Common Stock Repurchase i$-3.00MN/A

Short Interest & Institutional Ownership Analysis

MetricATECBSX
Shares Short i12.33M19.02M
Short Ratio i6.082.76
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i1,642,69712,773,240
Average Daily Volume (90 Day) i1,921,71910,174,867
Shares Outstanding i144.13M1.47B
Float Shares i116.52M1.48B
% Held by Insiders i0.21%0.00%
% Held by Institutions i0.69%0.94%

Dividend Analysis & Yield Comparison: Alphatec Holdings vs Boston Scientific

MetricATECBSX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A